<DOC>
	<DOCNO>NCT01180621</DOCNO>
	<brief_summary>The seasonal influenza vaccination program 2010-2011 first follow H1N1 pandemic 2009 . Many child either H1N1 infection adjuvanted H1N1 vaccine . Both H1N1 infection adjuvanted vaccine produce strong immune response could last time . The seasonal influenza vaccine fall trivalent inactivate product ( regular seasonal influenza vaccine ) , without adjuvant . It contain 3 strain kill , split-apart virus might circulate winter , include H1N1 pandemic strain . It theoretically possible give H1N1-containing seasonal vaccine people still immunity H1N1 virus could result frequent side-effects . However , good evidence pre-existing immunity strain vaccine increase side-effects . In short , could nothing ordinary fall would prudent check public flu vaccination program begin .</brief_summary>
	<brief_title>Evaluation Seasonal Influenza Vaccine 2010-2011 Young Children</brief_title>
	<detailed_description>This study ass safety seasonal influenza vaccination child receive one two dos adjuvanted H1N1 vaccine last year . It also measure residual immunity H1N1 virus immune responses seasonal vaccine . It carry new vaccine release general use accurate picture vaccine safety response Canadians . A total 200 child ( 50 site ) 12-59 month old , ask participate study . A research nurse conduct telephone screen potential participant determine eligible study . Volunteers must one two dos adjuvanted H1N1 vaccine January 31 , 2010 . To eligible participant need previous year seasonal flu vaccine ( TIV ) however , record . The study involve 1-2 vaccination visit 28 day apart . Those child receive previous dose TIV receive second dose visit # 2 . After vaccination , contact 1 7 day later description symptom experience . A blood sample request study visit ( 2 3 visit depend previous TIV history ) measure immune response seasonal vaccine . The study take 21-42 day complete , depend upon whether child receive previous dose seasonal TIV vaccination . The 4 study site Vancouver , Calgary , Montreal Halifax . Each subject 's parent ask keep daily note change injection site ( pain , redness , swell ) general symptom ( irritability , drowsiness , decrease appetite , sleep disturbance , sweat shivering , include axilla rectal temperature , 7 day vaccination . Major health change assess 21 day post vaccination .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written inform consent provide subject parent legal guardian . Subjects whose parent investigator believe comply requirement protocol ( i.e . return followup visit , record safety observation , able converse study personnel include telephone ) . Age 1259 month Visit 1 , male female Receipt one two dos Arepanrix ( adjuvanted H1N12009 vaccine , GlaxoSmithKline ( GSK ) ) 2009 document write record attest confident personal recollection ( window vaccination 1 October 2009 January 31 , 2010 ) . Systemic hypersensitivity hen ' egg Fluviral S/F vaccine component thimerosal History lifethreatening reaction influenza vaccine Receipt Arepanrix January 31st , 2010 Receipt nonstudy TIV ( Trivalent Influenza Vaccine ) 20102011 season Receipt live vaccine within 4 week inactivate vaccine within one week study entry plan administration nonstudy vaccine study period Thrombocytopenia bleed disorder contraindicates IM injection blood collection Receipt blood bloodderived product within past 3 month Chronic illness stage could interfere trial participation ( stable health condition acceptable , diabetes , lung disease , heart condition etc ) Immune compromise result medical condition , transplantation immunosuppressive medication , include topical aerosol medication Participation research study involve nonapproved drug medical device</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>vaccine</keyword>
	<keyword>Seasonal Influenza Vaccine</keyword>
	<keyword>Influenza Vaccine</keyword>
	<keyword>Vaccine Safety</keyword>
	<keyword>Vaccine Immunogenicity</keyword>
	<keyword>Fluviral 2010-2011</keyword>
</DOC>